• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于个体药代动力学的几种环孢素A治疗药物监测方法的比较。

Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.

作者信息

Wacke R, Rohde B, Engel G, Kundt G, Hehl E M, Bast R, Seiter H, Drewelow B

机构信息

Department of Clinical Pharmacology, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Rostock, Germany.

出版信息

Eur J Clin Pharmacol. 2000 Apr;56(1):43-8. doi: 10.1007/s002280050718.

DOI:10.1007/s002280050718
PMID:10853876
Abstract

OBJECTIVE

The clinical outcome of patients after organ transplantation is correlated with cyclosporin A (CyA) exposure. It is generally accepted that the area under the concentration-time curve (AUC) provides a reliable means for drug exposure. However, in routine therapeutic drug monitoring (TDM) of CyA, trough levels are mostly used. Currently, a number of different new concepts of CyA-TDM, including approaches such as single, double or triple time-point and abbreviated AUC determinations, have been introduced. The purpose of this study was to compare the predictive value of the different strategies of TDM.

METHODS

Calculations were based on 40 individual concentration time profiles after oral administration of CyA to patients who had been included into an ongoing prospective clinical trial. Non-compartmental analysis was used to calculate the AUC0-12h. Multiple linear regression was performed to describe the relationship between the different sets of blood concentrations and the respective AUC0-12h as well as to evaluate their predictive value regarding AUC. Predictive performance was assessed by prediction bias and prediction precision, which were estimated as the mean prediction error and root mean squared error, respectively.

RESULTS

When comparing the various combinations of time points, it was found that one-point approaches showed the strongest differences with regard to the predictive value; the associated r2 values differed from 0.203 to 0.792. The two and three time-point approaches showed lower differences - r2 0.802-0.972. The four-point and five-point approaches (r2 0.942-0.982) were the strongest predictors for CyA AUC0-12h. Relative bias ranged from -27.7% to 63.8% and changed significantly when multiple-point predictors were used. In those cases, the predictive performance improved. Considering the predictive performance as well as the smallest bias and highest prediction precision, C3, C1 + C3, C1 + C3 + C6 and C1 + C2 + C3 + C6 were the best predictors.

CONCLUSION

The results of this study indicate that in kidney transplant patients a clinically sufficient precise estimation of the CyA AUC is possible using two or three concentration time points.

摘要

目的

器官移植患者的临床结局与环孢素A(CyA)暴露相关。一般认为,浓度-时间曲线下面积(AUC)为药物暴露提供了可靠的衡量方法。然而,在CyA的常规治疗药物监测(TDM)中,大多使用谷浓度。目前,已经引入了许多不同的CyA-TDM新概念,包括单点、双点或三点以及简化AUC测定等方法。本研究的目的是比较不同TDM策略的预测价值。

方法

计算基于对纳入一项正在进行的前瞻性临床试验的患者口服CyA后的40个个体浓度-时间曲线。采用非房室分析计算AUC0-12h。进行多元线性回归以描述不同血药浓度组与各自AUC0-12h之间的关系,并评估它们对AUC的预测价值。通过预测偏差和预测精度评估预测性能,分别将其估计为平均预测误差和均方根误差。

结果

比较不同时间点组合时发现,单点法在预测价值方面差异最大;相关的r2值在0.203至0.792之间。两点和三点法差异较小——r2为0.802-0.972。四点和五点法(r2为0.942-0.982)是CyA AUC0-12h最强的预测指标。相对偏差范围为-27.7%至63.8%,使用多点预测指标时显著变化。在这些情况下,预测性能有所改善。综合考虑预测性能、最小偏差和最高预测精度,C3、C1 + C3、C1 + C3 + C6和C1 + C2 + C3 + C6是最佳预测指标。

结论

本研究结果表明,对于肾移植患者,使用两个或三个浓度时间点可以实现临床上对CyA AUC的足够精确估计。

相似文献

1
Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics.基于个体药代动力学的几种环孢素A治疗药物监测方法的比较。
Eur J Clin Pharmacol. 2000 Apr;56(1):43-8. doi: 10.1007/s002280050718.
2
[Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].肾移植后前24个月通过C2和AUC(0 - 4)进行环孢素治疗监测的疗效
Vojnosanit Pregl. 2008 Feb;65(2):119-27. doi: 10.2298/vsp0802119v.
3
Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.肾移植患者的环孢素监测:在预测药物暴露方面,估算曲线下面积的两点或三点法优于谷浓度。
Ther Drug Monit. 1998 Jun;20(3):276-83. doi: 10.1097/00007691-199806000-00007.
4
Evolution of the therapeutic drug monitoring of cyclosporine.环孢素治疗药物监测的演变
Transplant Proc. 2004 Mar;36(2 Suppl):420S-425S. doi: 10.1016/j.transproceed.2004.01.054.
5
Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.环孢素的治疗药物监测及使用单时间点策略的曲线下面积预测:基于峰浓度数据的评估
Biopharm Drug Dispos. 2015 Dec;36(9):575-86. doi: 10.1002/bdd.1967. Epub 2015 Aug 20.
6
Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.预测长期服用霉酚酸酯联合环孢素或他克莫司的心脏移植患者曲线下面积的最佳单一时间点。
J Heart Lung Transplant. 2005 Oct;24(10):1614-8. doi: 10.1016/j.healun.2004.12.112.
7
Cyclosporin A absorption profiles in children with nephrotic syndrome.肾病综合征患儿中环孢素A的吸收情况
Pediatr Nephrol. 2005 Jul;20(7):910-3. doi: 10.1007/s00467-005-1844-6. Epub 2005 Apr 23.
8
New strategies of cyclosporine monitoring in heart transplantation: initial results.
Transplant Proc. 2003 Aug;35(5):1984-7. doi: 10.1016/s0041-1345(03)00657-2.
9
A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.在接受含环孢素A和不含环孢素A免疫抑制方案的稳定心脏移植患者中,通过有限采样策略监测霉酚酸暴露时,测量谷浓度与简化AUC估计值的比较。
Clin Ther. 2006 Jun;28(6):893-905. doi: 10.1016/j.clinthera.2006.06.015.
10
Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.肺移植中他克莫司的药代动力学:监测新策略
J Heart Lung Transplant. 2005 Sep;24(9):1315-9. doi: 10.1016/j.healun.2004.09.001.

引用本文的文献

1
Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.日本肾移植患者中环孢素A的群体药代动力学:单中心综合分析
Eur J Clin Pharmacol. 2017 Sep;73(9):1111-1119. doi: 10.1007/s00228-017-2279-2. Epub 2017 Jun 15.
2
Dose adjustment strategy of cyclosporine A in renal transplant patients: evaluation of anthropometric parameters for dose adjustment and C0 vs. C2 monitoring in Japan, 2001-2010.环孢素 A 在肾移植受者中的剂量调整策略:2001-2010 年日本对剂量调整的人体测量参数和 C0 与 C2 监测的评估。
Int J Med Sci. 2013 Sep 23;10(12):1665-73. doi: 10.7150/ijms.6727. eCollection 2013.
3
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
环孢素在异基因造血干细胞移植中的群体药代动力学:重点关注有限采样策略。
Br J Clin Pharmacol. 2012 Apr;73(4):553-63. doi: 10.1111/j.1365-2125.2011.04116.x.
4
Prediction of cyclosporine A blood levels: an application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy.环孢素A血药浓度的预测:基于自适应网络的模糊推理系统(ANFIS)在辅助药物治疗中的应用。
Eur J Clin Pharmacol. 2008 Aug;64(8):807-14. doi: 10.1007/s00228-008-0490-x. Epub 2008 May 6.
5
[Cyclosporine monitoring in patients with chronic uveitis].
Ophthalmologe. 2005 Apr;102(4):349-54. doi: 10.1007/s00347-005-1174-x.
6
Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.在心脏移植受者移植后的第一年,采用贝叶斯估计或多线性回归的有限采样策略用于监测环孢素AUC(0 - 12)。
Eur J Clin Pharmacol. 2003 Apr;58(12):813-20. doi: 10.1007/s00228-003-0559-5. Epub 2003 Mar 6.
7
Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.用于预测肾移植受者每日一次环孢素微乳剂稳态暴露量的群体药代动力学模型。
Clin Pharmacokinet. 2002;41(1):59-69. doi: 10.2165/00003088-200241010-00005.